Cryosite Ltd
ASX:CTE

Watchlist Manager
Cryosite Ltd Logo
Cryosite Ltd
ASX:CTE
Watchlist
Price: 0.85 AUD Market Closed
Market Cap: 41.5m AUD
Have any thoughts about
Cryosite Ltd?
Write Note

Cryosite Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cryosite Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Cryosite Ltd
ASX:CTE
Other Long-Term Assets
AU$8.3m
CAGR 3-Years
-13%
CAGR 5-Years
-12%
CAGR 10-Years
30%
Anteotech Ltd
ASX:ADO
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proteomics International Laboratories Ltd
ASX:PIQ
Other Long-Term Assets
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Other Long-Term Assets
AU$4.7m
CAGR 3-Years
5%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Genetic Signatures Ltd
ASX:GSS
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Other Long-Term Assets
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cryosite Ltd
Glance View

Market Cap
41.5m AUD
Industry
Life Sciences Tools & Services

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

CTE Intrinsic Value
0.67 AUD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Cryosite Ltd's Other Long-Term Assets?
Other Long-Term Assets
8.3m AUD

Based on the financial report for Jun 30, 2024, Cryosite Ltd's Other Long-Term Assets amounts to 8.3m AUD.

What is Cryosite Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
30%

Over the last year, the Other Long-Term Assets growth was -12%. The average annual Other Long-Term Assets growth rates for Cryosite Ltd have been -13% over the past three years , -12% over the past five years , and 30% over the past ten years .

Back to Top